Caley-Reidenbach Consulting, LLP
541-929-7435
contact AT caleyreidenbach.com 

Oncology

General

  • Howard SC, Harvey RD, Kovacsovics T, Wood N. Life-threatening chemotoxicity: from prevention to management. Online CME presentation. Prepared April 2014. [FR, collaborating writer]

  • Caley BA. Added benefits: what healthcare reform means for people with cancer. CURE: Cancer Updates, Research and Education. Published online December 10, 2013.

  • Caley BA. Non-traditional methods to pay for cancer care pays off. CURE: Cancer Updates, Research and Education. Published online November 25, 2013.

  • "Oncology" (slide set). American Geriatrics Society, April 2007. [BAC and FR, writers]

  • Educational website content about recent developments in cancer (biologic and targeted therapies, gene therapy, therapeutic vaccines, and individualized treatment). Prepared January to June 2007. [BAC, writer]

  • Caley BA. The future of cancer research: recent discoveries will change the direction of treatment. CURE: Cancer Updates, Research and Education. 2005;4(4):48-55.

  • Quantitative literature analyses about: a hematopoietic growth factor (prepared April 2005), a novel leukemia drug (March 2005), a novel taxane (February 2005), monoclonal antibodies for breast cancer (February 2005), a novel anthracenedione (February 2005), and various antimicrobials (January 2005). [BAC, researcher]

  • Walsh JME. Controversies in cancer prevention and screening. Adv Stud Med. 2003;3(6):316-325. [BAC and FR, collaborating writers]

Basal cell carcinoma

  • Needs assessment for a CME program for dermatologists and dermatologic oncologists about diagnosis and treatment of basal cell carcinoma. Prepared August 2012. [BAC and FR, writers]

Bladder cancer

Breast cancer

  • Sequencing therapy in HER2-positive breast cancer: a conversation with Sara Hurvitz, MD. Online CME presentation. Prepared April 2015. [BAC, collaborating writer]

  • DeMartini W. Application of MRI for treatment decisions in breast cancer. Online CME presentation. Prepared September 2014. [BAC, collaborating writer]

  • Needs assessment for a CME program about metastatic breast cancer. Prepared May 2013. [BAC, writer]

  • Needs assessment for a CME program for oncologists about using nontaxane microtubule dynamics inhibitors to treat metastatic breast cancer. Prepared May 2013. [BC, writer]

  • Modi S. First-line treatment for newly diagnosed HER2-positive metastatic breast cancer. Online CME presentation. Prepared March 2013. [FR, collaborating writer]

  • Hurvitz S. Recurrent, previously treated HER2-positive metastatic breast cancer. Online CME presentation. Online CME presentation. Prepared February 2013. [BAC, collaborating writer]

  • Clinical trial report about inflammatory local recurrence after breast-conserving therapy for breast cancer. Prepared September 2012. [FR, collaborating editor]

  • Needs assessment for CME program on managing pretreated metastatic breast cancer, prepared May 2010. [BAC and FR, writers]

  • Benchmarking report on current third-line treatment of breast cancer. Prepared July 2009. [BAC, writer]

  • Slide sets on breast cancer-related abstracts and posters presented at ASCO 2009. Prepared June 2009. [BAC, writer]

  • Detailed summaries of published journal articles about anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer. Prepared June to September 2008. [FR, writer]

  • Three posters for ASCO annual meeting about anti-angiogenic treatment of breast and ovarian cancer. Prepared April 2008. [FR, collaborating writer]

  • Same-day Internet reports from the San Antonio Breast Cancer Symposium, prepared for CURE magazine, December 2008. [BAC, writer]

  • Caley BA. In situ breast cancer: is it really cancer? CURE: Cancer Updates, Research and Education. 2006;5(4):18-23,28. Also wrote sidebar: Do women under 50 need mammograms?

  • Preventing death from breast cancer and prostate cancer. Prepared for Taking Care, November 2005. [BAC, writer]

  • Meeting report, national breast cancer advisory board. Prepared June 2005. [FR, writer]

  • Meeting report, national breast cancer advisory board. Prepared June 2004. [BAC, writer]

  • Caley BA and Reidenbach F. Expanding options for advanced breast cancer. CURE: Cancer Updates, Research and Education. 2003;2(3):47-53.

  • Reidenbach F. Gabapentin may relieve tamoxifen-related hot flushes. Lancet Oncol. 2002;3:393.

  • Reidenbach F. Novel predictor of breast cancer survival called the most powerful to date. Reuters news for physicians, 11-14-2002.

  • Reidenbach F. Anthracycline/taxane neoadjuvant chemotherapy advised for breast cancer. Reuters news for physicians, 4-9-2002.

  • Reidenbach F. Clues to why breast cancer more often fatal in African Americans. Reuters news for physicians, 2-7-2002.

  • Reidenbach F. Postmastectomy radiation may be warranted after response to chemotherapy. Reuters news for physicians, 1-30-2002.

  • Reidenbach F. Incident breast lesions found on MRI unlikely to be malignant. Reuters news for physicians, 12-2-1998.

  • Reidenbach F. Adjuvant chemotherapy prolongs survival in high-risk node-negative breast cancer. Reuters news for physicians, 10-30-1998.

Cancer surgery

Carcinoid tumor

  • Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor. Prepared November 2005. [FR, writer]

Cervical cancer

  • CME newsletter about the burden of cervical cancer. Prepared September 2006. [FR, writer]

  • Reidenbach F. Public funding of Pap tests linked to lower rate of invasive cervical cancer. Reuters news for physicians, 7-5-2002.

  • Reidenbach F. Enhanced Pap testing cost effective for infrequent screening. Reuters news for physicians, 1-27-1999.

Colorectal cancer

  • Chu E. Clinical challenges in metastatic colorectal cancer: beyond the first line. Online CME presentation. Prepared July 2014. [BAC, collaborating writer]

  • McIntyre KR. New targeted agents in metastatic colorectal cancer: a guide for oncology nurses. Online CME presentation. Prepared December 2013. [BAC, collaborating writer]

  • Script for sales training video on KRAS as a biomarker for response to treatment of colorectal cancer. Prepared October 2009. [BAC, writer]

  • Detailed summaries of published journal articles about anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer. Prepared June to September 2008. [FR, writer]

  • Educational website content for patients with colorectal cancer. Prepared January to June 2007. [BAC, writer]

  • Poster for ASCO annual meeting about outcome measures for clinical trials of agents for metastatic colorectal cancer. Prepared April 2006. [FR, collaborating writer]

  • Review article about the use of an anti-angiogenesis agent in the treatment of metastatic renal cell carcinoma. Prepared January 2006. [FR, collaborating writer]

  • Reidenbach F. Gene may help suppress colorectal cancer. Reuters news for the public, 2-28-2002.

  • Reidenbach F. Calcium reduces risk of colorectal polyps. Reuters news for the public, 1-13-1999.

  • Reidenbach F. Clinical findings predict DNA-repair gene mutations in colorectal cancer. Reuters news for physicians, 8-20-1998.

Head and neck cancer

  • Review article about the use of immunotherapy in head and neck cancer. Prepared November 2008. [BAC and FR, collaborating writers]

  • Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor. Prepared November 2005. [FR, writer]

Lung cancer

  • Training materials for sales representatives about targeted therapy for non-small-cell lung cancer. Prepared June 2008, February 2009, and September 2009. [FR, writer]

  • Qualitative literature review on video-assisted thoroscopic lobectomy. Prepared May 2007. [FR, researcher]

  • Educational website content for patients with non-small-cell or small-cell lung cancer. Prepared January to June 2007. [BAC, writer]

  • The health consequences of smoking. In: Attorneys’ Textbook of Medicine. New York, NY: Matthew Bender, 2006. [BAC, collaborating writer]

  • Review article about trends in chemotherapy for lung cancer. Prepared July 2005. [FR, collaborating writer]

  • Quantitative literature analysis regarding chemotherapy for non-small-cell lung cancer. Prepared April 2004. [BAC, researcher]

  • Reidenbach F. Early radiation advised for limited-stage small-cell lung cancer. Reuters news for physicians, 8-7-2002.

  • Reidenbach F. Spiral CT promising for lung cancer screening. Reuters news for the public, 8-2-2002.

  • Reidenbach F. p53 appears to inhibit angiogenesis in non-small-cell lung cancer. Reuters news for physicians, 3-13-2002.

Neuroendocrine tumors

  • Section 3 (review of clinical evidence) of an AMCP dossier for a drug used in the treatment of gastropancreatic neuroendocrine tumors. Prepared December 2014. [FR, writer]

  • Phan A, Kulke MH, Yao JC, Strosberg JS, Kunz PL. The evolving treatment landscape of pancreatic neuroendocrine tumors. Online CME presentation. Prepared April 2013. [BC, collaborating writer]

  • Saif MW, Scheiman JM. Standard of care for pancreatic endocrine tumors. Online CME program. Prepared April 2011. [BAC, collaborating writer]

Ovarian cancer

  • Detailed summaries of published journal articles about anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer. Prepared June to September 2008. [FR, writer]

  • Three posters for ASCO annual meeting about anti-angiogenic treatment of breast and ovarian cancer. Prepared April 2008. [FR, collaborating writer]

  • Reidenbach F. Blood test may screen for ovarian cancer. Reuters news for the public, 8-25-1998.

Pathology and staging

  • Pathology and staging. CURE: Cancer Updates, Research and Education. 2007;6(1):8,11-13. [BAC, writer]

Pancreatic cancer

  • Morton A, Jacobs CB, Valone T. The nurse view: management of pancreatic adenocarcinoma. Online continuing education presentation. Prepared October 2014. [FR, collaborating writer]

  • Training materials for sales representatives about targeted therapy for pancreatic cancer. Prepared June 2008, February 2009, and September 2009. [FR, writer]

  • Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor. Prepared November 2005. [FR, writer]

  • Reidenbach F. Statins might fight spread of pancreatic cancer. Reuters news for the public, 3-29-2002.

Prostate cancer

  • Ryan CJ. Treating bone metastases in castration-resistant prostate cancer. Case-based online CME presentation. Prepared May 2015. [BAC, collaborating writer]

  • Needs assessment for a CME program for oncologists about metastatic castration-resistant prostate cancer. Prepared October 2012. [BAC and FR, writers][

  • Protection against bone loss in patients with nonmetastatic prostate cancer treated with androgen deprivation therapy. Review article for urologic nurses, prepared September 2009. [FR, collaborating writer]

  • Review article about the safety of testosterone replacement therapy with regard to prostate cancer. Prepared April 2006. [BAC and FR, collaborating writers]

  • Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor. Prepared November 2005. [FR, writer]

  • Preventing death from breast cancer and prostate cancer. Prepared for Taking Care, November 2005. [BAC, writer]

  • Reidenbach F. Telomerase immunoreactivity of prostate tumors may have diagnostic value. Reuters news for physicians, 12-27-2002.

  • Reidenbach F. Level of p27 predicts outcome in localized prostate cancer. Reuters news for physicians, 6-17-1998.

Renal cell carcinoma

Sarcoma

Supportive care generally

  • Meeting report, national advisory board on supportive care in cancer, prepared September 2005. [FR, writer]

  • Posters for ASH, ASCO, and MASCC/ISOO annual meetings, 2005. Multiple topics regarding supportive care for cancer patients. [FR, collaborating writer]

  • Posters for ASCO and MASCC/ISOO annual meetings, 2004. Multiple topics regarding supportive care for cancer patients. [FR, collaborating writer]

Supportive care -- anemia

  • Strategic analyses for the manufacturer of an erythropoiesis-stimulating agent. Prepared May to December 2009. [BAC, researcher]

  • Quantitative literature analysis about erythropoiesis-stimulating agents. Prepared May 2008. [BAC, researcher]

  • Quantitative literature analysis about erythropoiesis-stimulating agents. Prepared May 2006. [BAC, researcher]

Supportive care -- anticoagulation

  • Needs assessment for CME program on preventing venous thromboembolism in cancer patients. Prepared June 2010. [BAC and FR, writers]

Supportive care -- bone metastases

  • Ryan CJ. Treating bone metastases in castration-resistant prostate cancer. Case-based online CME presentation. Prepared May 2015. [BAC, collaborating writer]

  • Monograph about the use of denosumab to prevent cancer treatment-induced bone loss. Prepared June 2010. [FR, collaborating writer]

  • Protection against bone loss in patients with nonmetastatic prostate cancer treated with androgen deprivation therapy. Review article for urology nurses, prepared September 2009. [FR, collaborating writer]

  • Slide library summarizing the design and results of more than 50 clinical trials on the use of bisphosphonates to treat skeletal-related events in breast, lung, prostate, and renal cancer. Prepared December 2007 to July 2008. [BAC and FR, writers]

Supportive care -- mucositis

  • Mehta VK, Abboud-Finch M, Petersen JA, Marron JT. Impact of mucositis on patient experience during treatment for head and neck cancer. J Clin Oncol. 2008;26(15S):abstract 17034. [FR, collaborating writer]

  • 2 investigator newsletters reporting on clinical trials of palifermin. Prepared September 2006 and March 2007. [FR, writer]

Supportive care -- neutropenia

Supportive care -- tumor lysis syndrome

Survivorship

  • Caley BA. Taking control: cancer patients deal with fear. CURE: Cancer Updates, Research and Education. 2006;5(3):64-68.

  • Caley BA. Going against the odds [living with metastatic cancer]. CURE: Cancer Updates, Research and Education. 2005;4(2):56-58,60. Also wrote two of the three sidebars to this article: Disrupting metastasis; The future of metastasis treatment.

  • Herman R. Cultural diversity and cancer patient education. Poster presented at the 2004 meeting of the Oncology Nursing Society. [FR, collaborating writer]

  • Reidenbach F. Conceiving solutions: Fertility and cancer treatment. CURE: Cancer Updates, Research and Education. 2002;1(4):22-26.

  • Reidenbach F. Chemotherapy safe in pregnancy. Lancet Oncol. 2002;3:128.

  • Reidenbach F. Mental difficulties can persist long after chemotherapy. Reuters news for the public, 2-11-2002.

Targeted therapy generally

  • CME slide set about the differences between small-molecule drugs, biologics, and biosimilars. Prepared October 2010. [BAC and FR, writers]

  • Lemmens L. Management of dermatologic toxicities related to epidermal growth factor receptor inhibitor therapy across Europe. Poster presented at the 2010 meeting of the European Oncologic Nursing Society. [FR, collaborating writer]

  • Quantitative literature review about angiogenesis inhibitors. Prepared May 2006. [BAC, researcher]

  • Review article about the safety of using anti-angiogenic therapy in elderly patients or patients with poor performance status. Prepared January 2006. [FR, collaborating writer]

  • Meeting report, national advisory board on angiogenesis inhibitors. Prepared December 2005. [FR, writer]

  • Educational newsletter for sales representatives about targeted therapy. Prepared Spring 2004. [FR, writer]

  • Reidenbach F. Angiogenesis inhibitor plus paclitaxel well tolerated in phase 1 trial. Reuters news for physicians, 12-5-2002.

  • Reidenbach F. Resistance to antiangiogenic agents may reflect variance in tumor biology. Reuters news for physicians, 10-03-2002.

  • Reidenbach F. First cholinergic pathway for angiogenesis identified. Reuters news for physicians, 9-10-2002.

Thyroid cancer

  • Are thyroid nodules cancerous? Prepared for Taking Care, October 2005. [BAC, writer]